Recent Finacing
Recent Raise
Safi Biotherapeutics develops allogeneic, stem-cell–sourced bio-manufactured red blood cells with tailored immuno-phenotypes for multi-unit chronic and universal-donor transfusions, advancing manufacturing scale-up and IND-ready clinical production.
